SLCO1B1 and Hepatic fibrosis: In this study, we found that SLB-M treatment ameliorated liver fibrosis by reducing collagen deposition and restoring tissue integrity by promoting the Fxr to appropriately decrease conjugated BAs by promoting Slco1a1, Slco1b1, and Sult2a8 expression.